INCYTE CORPORATION Revenues
INCYTE CORPORATION (INCY) reported Revenues of $3.39 billion for the 12-month period ending 2022-12-31, per its 10-K filed 2023-02-07.
Discontinued › Income Statement › Revenue
us-gaap:Revenues · last filed 2023-02-07
- INCYTE CORPORATION revenues for the quarter ending 2022-06-30 was $911.40M, a 29.15% increase year-over-year.
- INCYTE CORPORATION revenues for the quarter ending 2022-03-31 was $733.24M, a 21.25% increase year-over-year.
- INCYTE CORPORATION revenues for the quarter ending 2021-12-31 was $862.85M, a 9.29% increase year-over-year.
- INCYTE CORPORATION revenues for the quarter ending 2021-09-30 was $812.99M, a 30.99% increase year-over-year.
- INCYTE CORPORATION revenues for fiscal 2022 was $3.39B, a 13.67% increase from fiscal 2021.
- INCYTE CORPORATION revenues for fiscal 2021 was $2.99B, a 11.98% increase from fiscal 2020.
- INCYTE CORPORATION revenues for fiscal 2020 was $2.67B, a 23.53% increase from fiscal 2019.
- INCYTE CORPORATION revenues for fiscal 2019 was $2.16B, a 14.71% increase from fiscal 2018.
| Period end | Revenues 3 month | Revenues 6 month | Revenues 9 month | Revenues 12 month |
|---|---|---|---|---|
| 2022-12-31 | $3.39B 10-K · filed 2023-02-07 | |||
| 2022-06-30 | $911.40M 10-Q · filed 2022-08-02 | $1.64B 10-Q · filed 2022-08-02 | $2.51B derived: sum of 3 quarters · filed 2023-02-07 | $3.32B derived: sum of 4 quarters · filed 2023-02-07 |
| 2022-03-31 | $733.24M 10-Q · filed 2022-05-03 | $1.60B derived: sum of 2 quarters · filed 2023-02-07 | $2.41B derived: sum of 3 quarters · filed 2023-02-07 | $3.11B derived: sum of 4 quarters · filed 2023-02-07 |
| 2021-12-31 | $862.85M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-07 | $1.68B derived: sum of 2 quarters · filed 2023-02-07 | $2.38B derived: sum of 3 quarters · filed 2023-02-07 | $2.99B 10-K · filed 2023-02-07 |
| 2021-09-30 | $812.99M 10-Q · filed 2021-11-02 | $1.52B derived: sum of 2 quarters · filed 2022-08-02 | $2.12B 10-Q · filed 2021-11-02 | $2.91B derived: sum of 4 quarters · filed 2023-02-07 |
| 2021-06-30 | $705.71M 10-Q · filed 2022-08-02 | $1.31B 10-Q · filed 2022-08-02 | $2.10B derived: sum of 3 quarters · filed 2023-02-07 | $2.72B derived: sum of 4 quarters · filed 2023-02-07 |
| 2021-03-31 | $604.72M 10-Q · filed 2022-05-03 | $1.39B derived: sum of 2 quarters · filed 2023-02-07 | $2.01B derived: sum of 3 quarters · filed 2023-02-07 | $2.70B derived: sum of 4 quarters · filed 2023-02-07 |
| 2020-12-31 | $789.51M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-07 | $1.41B derived: sum of 2 quarters · filed 2023-02-07 | $2.10B derived: sum of 3 quarters · filed 2023-02-07 | $2.67B 10-K · filed 2023-02-07 |
| 2020-09-30 | $620.64M 10-Q · filed 2021-11-02 | $1.31B derived: sum of 2 quarters · filed 2021-11-02 | $1.88B 10-Q · filed 2021-11-02 | $2.46B derived: sum of 4 quarters · filed 2022-02-08 |
| 2020-06-30 | $688.04M 10-Q · filed 2021-08-03 | $1.26B 10-Q · filed 2021-08-03 | $1.84B derived: sum of 3 quarters · filed 2022-02-08 | $2.39B derived: sum of 4 quarters · filed 2022-02-08 |
| 2020-03-31 | $568.51M 10-Q · filed 2021-05-04 | $1.15B derived: sum of 2 quarters · filed 2022-02-08 | $1.70B derived: sum of 3 quarters · filed 2022-02-08 | $2.23B derived: sum of 4 quarters · filed 2022-02-08 |
| 2019-12-31 | $579.39M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-08 | $1.13B derived: sum of 2 quarters · filed 2022-02-08 | $1.66B derived: sum of 3 quarters · filed 2022-02-08 | $2.16B 10-K · filed 2022-02-08 |
| 2019-09-30 | $551.58M 10-Q · filed 2020-11-05 | $1.08B derived: sum of 2 quarters · filed 2020-11-05 | $1.58B 10-Q · filed 2020-11-05 | $2.11B derived: sum of 4 quarters · filed 2021-02-09 |
| 2019-06-30 | $529.93M 10-Q · filed 2020-08-04 | $1.03B 10-Q · filed 2020-08-04 | $1.56B derived: sum of 3 quarters · filed 2021-02-09 | $2.01B derived: sum of 4 quarters · filed 2021-02-09 |
| 2019-03-31 | $497.86M 10-Q · filed 2020-05-05 | $1.03B derived: sum of 2 quarters · filed 2021-02-09 | $1.48B derived: sum of 3 quarters · filed 2021-02-09 | $2.00B derived: sum of 4 quarters · filed 2021-02-09 |
| 2018-12-31 | $528.40M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-09 | $978.09M derived: sum of 2 quarters · filed 2021-02-09 | $1.50B derived: sum of 3 quarters · filed 2021-02-09 | $1.88B 10-K · filed 2021-02-09 |
| 2018-09-30 | $449.68M 10-Q · filed 2019-10-29 | $971.20M derived: sum of 2 quarters · filed 2019-10-29 | $1.35B 10-Q · filed 2019-10-29 | $1.80B derived: sum of 4 quarters · filed 2019-10-29 |
| 2018-06-30 | $521.52M 10-Q · filed 2019-07-30 | $903.80M 10-Q · filed 2019-07-30 | $1.35B derived: sum of 3 quarters · filed 2019-07-30 | $1.73B derived: sum of 4 quarters · filed 2019-07-30 |
| 2018-03-31 | $382.28M 10-Q · filed 2019-04-30 | $826.44M derived: sum of 2 quarters · filed 2019-04-30 | $1.21B derived: sum of 3 quarters · filed 2019-04-30 | $1.53B derived: sum of 4 quarters · filed 2019-04-30 |
| 2017-12-31 | $444.16M 10-K · filed 2018-02-15 | $825.69M derived: sum of 2 quarters · filed 2018-10-30 | $1.15B derived: sum of 3 quarters · filed 2018-10-30 | $1.54B 10-K · filed 2020-02-13 |
| 2017-09-30 | $381.53M 10-Q · filed 2018-10-30 | $707.98M derived: sum of 2 quarters · filed 2018-10-30 | $1.09B 10-Q · filed 2018-10-30 | $1.42B derived: sum of 4 quarters · filed 2018-10-30 |
| 2017-06-30 | $326.44M 10-Q · filed 2018-07-31 | $710.53M 10-Q · filed 2018-07-31 | $1.04B derived: sum of 3 quarters · filed 2018-07-31 | $1.31B derived: sum of 4 quarters · filed 2018-07-31 |
| 2017-03-31 | $384.08M 10-Q · filed 2018-05-01 | $710.58M derived: sum of 2 quarters · filed 2018-05-01 | $980.05M derived: sum of 3 quarters · filed 2018-05-01 | $1.23B derived: sum of 4 quarters · filed 2018-05-01 |
| 2016-12-31 | $326.50M 10-K · filed 2018-02-15 | $595.97M derived: sum of 2 quarters · filed 2018-02-15 | $842.25M derived: sum of 3 quarters · filed 2018-02-15 | $1.11B 10-K · filed 2019-02-14 |
| 2016-09-30 | $269.47M 10-K · filed 2018-02-15 | $515.76M derived: sum of 2 quarters · filed 2018-02-15 | $779.22M 10-Q · filed 2017-10-31 | $1.02B derived: sum of 4 quarters · filed 2018-02-15 |
| 2016-06-30 | $246.29M 10-K · filed 2018-02-15 | $509.75M 10-Q · filed 2017-08-01 | $753.63M derived: sum of 3 quarters · filed 2018-02-15 | $941.24M derived: sum of 4 quarters · filed 2018-02-15 |
| 2016-03-31 | $263.46M 10-K · filed 2018-02-15 | $507.35M derived: sum of 2 quarters · filed 2018-02-15 | $694.96M derived: sum of 3 quarters · filed 2018-02-15 | $857.94M derived: sum of 4 quarters · filed 2018-02-15 |
| 2015-12-31 | $243.88M 10-K · filed 2017-02-14 | $431.49M derived: sum of 2 quarters · filed 2017-02-14 | $594.48M derived: sum of 3 quarters · filed 2017-02-14 | $753.75M 10-K · filed 2018-02-15 |
| 2015-09-30 | $187.61M 10-K · filed 2017-02-14 | $350.60M derived: sum of 2 quarters · filed 2017-02-14 | $509.87M 10-Q · filed 2016-11-01 | $633.84M derived: sum of 4 quarters · filed 2017-02-14 |
| 2015-06-30 | $162.98M 10-K · filed 2017-02-14 | $322.26M 10-Q · filed 2016-08-09 | $446.23M derived: sum of 3 quarters · filed 2017-02-14 | $644.38M derived: sum of 4 quarters · filed 2017-02-14 |
| 2015-03-31 | $159.28M 10-K · filed 2017-02-14 | $283.25M derived: sum of 2 quarters · filed 2017-02-14 | $481.39M derived: sum of 3 quarters · filed 2017-02-14 | $580.98M derived: sum of 4 quarters · filed 2017-02-14 |
| 2014-12-31 | $123.97M 10-K · filed 2016-02-12 | $322.12M derived: sum of 2 quarters · filed 2016-02-12 | $421.70M derived: sum of 3 quarters · filed 2016-02-12 | $511.50M 10-K · filed 2017-02-14 |
| 2014-09-30 | $198.15M 10-K · filed 2016-02-12 | $297.73M derived: sum of 2 quarters · filed 2016-02-12 | $387.52M 10-Q · filed 2015-11-03 | $484.59M derived: sum of 4 quarters · filed 2016-02-12 |
| 2014-06-30 | $99.58M 10-K · filed 2016-02-12 | $189.37M 10-Q · filed 2015-08-04 | $286.45M derived: sum of 3 quarters · filed 2016-02-12 | $371.57M derived: sum of 4 quarters · filed 2016-02-12 |
| 2014-03-31 | $89.79M 10-K · filed 2016-02-12 | $186.86M derived: sum of 2 quarters · filed 2016-02-12 | $271.99M derived: sum of 3 quarters · filed 2016-02-12 | $373.66M derived: sum of 4 quarters · filed 2016-02-12 |
| 2013-12-31 | $97.07M 10-K · filed 2015-02-17 | $182.19M derived: sum of 2 quarters · filed 2015-02-17 | $283.87M derived: sum of 3 quarters · filed 2015-02-17 | $354.95M 10-K · filed 2016-02-12 |
| 2013-09-30 | $85.12M 10-K · filed 2015-02-17 | $186.80M derived: sum of 2 quarters · filed 2015-02-17 | $257.88M 10-Q · filed 2014-10-30 | $371.72M derived: sum of 4 quarters · filed 2015-02-17 |
| 2013-06-30 | $101.67M 10-K · filed 2015-02-17 | $172.75M 10-Q · filed 2014-07-31 | $286.60M derived: sum of 3 quarters · filed 2015-02-17 | $347.09M derived: sum of 4 quarters · filed 2015-02-17 |
| 2013-03-31 | $71.08M 10-K · filed 2015-02-17 | $184.92M derived: sum of 2 quarters · filed 2015-02-17 | $245.41M derived: sum of 3 quarters · filed 2015-02-17 | $331.96M derived: sum of 4 quarters · filed 2015-02-17 |
| 2012-12-31 | $113.84M 10-K · filed 2014-02-21 | $174.34M derived: sum of 2 quarters · filed 2014-02-21 | $260.88M derived: sum of 3 quarters · filed 2014-02-21 | $297.06M 10-K · filed 2015-02-17 |
| 2012-09-30 | $60.49M 10-K · filed 2014-02-21 | $147.03M derived: sum of 2 quarters · filed 2014-02-21 | $183.21M 10-Q · filed 2013-10-31 | $212.10M derived: sum of 4 quarters · filed 2014-02-21 |
| 2012-06-30 | $86.54M 10-K · filed 2014-02-21 | $122.72M 10-Q · filed 2013-08-01 | $151.61M derived: sum of 3 quarters · filed 2014-02-21 | $168.39M derived: sum of 4 quarters · filed 2014-02-21 |
| 2012-03-31 | $36.18M 10-K · filed 2014-02-21 | $65.07M derived: sum of 2 quarters · filed 2014-02-21 | $81.85M derived: sum of 3 quarters · filed 2014-02-21 | $98.66M derived: sum of 4 quarters · filed 2014-02-21 |
| 2011-12-31 | $28.89M 10-K · filed 2013-02-21 | $45.67M derived: sum of 2 quarters · filed 2013-02-21 | $62.48M derived: sum of 3 quarters · filed 2013-02-21 | $94.45M 10-K · filed 2014-02-21 |
| 2011-09-30 | $16.78M 10-K · filed 2013-02-21 | $33.59M derived: sum of 2 quarters · filed 2013-02-21 | $65.56M 10-Q · filed 2012-11-01 | $151.44M derived: sum of 4 quarters · filed 2013-02-21 |
| 2011-06-30 | $16.81M 10-K · filed 2013-02-21 | $48.78M 10-Q · filed 2012-08-03 | $134.65M derived: sum of 3 quarters · filed 2013-02-21 | $151.53M derived: sum of 4 quarters · filed 2013-02-21 |
| 2011-03-31 | $31.97M 10-K · filed 2013-02-21 | $117.84M derived: sum of 2 quarters · filed 2013-02-21 | $134.72M derived: sum of 3 quarters · filed 2013-02-21 | $184.56M derived: sum of 4 quarters · filed 2013-02-21 |
| 2010-12-31 | $85.87M 10-K · filed 2012-02-22 | $102.74M derived: sum of 2 quarters · filed 2012-02-22 | $152.59M derived: sum of 3 quarters · filed 2012-02-22 | $169.88M 10-K · filed 2013-02-21 |
| 2010-09-30 | $16.87M 10-K · filed 2012-02-22 | $66.72M derived: sum of 2 quarters · filed 2012-02-22 | $84.01M 10-Q · filed 2011-10-27 | |
| 2010-06-30 | $49.85M 10-K · filed 2012-02-22 | $67.14M 10-Q · filed 2011-07-28 | ||
| 2010-03-31 | $17.29M 10-K · filed 2012-02-22 | |||
| 2009-12-31 | $9.27M 10-K · filed 2012-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| IQVIA HOLDINGS INC. (IQV) | United States | $45.926B | 20.54 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |